ACHE and amyotrophic lateral sclerosis: Together with these in vivo results, these approaches could also provide powerful tools to test this hypothesis and eventually to validate compounds that are capable of boosting AChE expression at the NMJ as potential therapeutic avenues in ALS and related neuromuscular disorders.